Works matching AU Habermann, Thomas M.
Results: 169
Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 3, p. 396, doi. 10.1002/ijc.34266
- By:
- Publication type:
- Article
Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 3, p. 535, doi. 10.1002/ijc.33541
- By:
- Publication type:
- Article
Author reply.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Testicular lymphoma is associated with a high incidence of extranodal recurrence.
- Published in:
- 2000
- By:
- Publication type:
- journal article
If you feed them, they will come: A prospective study of the effects of complimentary food on attendance and physician attitudes at medical grand rounds at an academic medical center.
- Published in:
- BMC Medical Education, 2007, v. 7, p. 22, doi. 10.1186/1472-6920-7-22
- By:
- Publication type:
- Article
New developments in the management of diffuse large B-cell lymphoma.
- Published in:
- Hematology, 2012, v. 17, p. 93, doi. 10.1179/102453312X13336169156014
- By:
- Publication type:
- Article
Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
- Published in:
- International Journal of Dermatology, 2017, v. 56, n. 11, p. 1125, doi. 10.1111/ijd.13653
- By:
- Publication type:
- Article
Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
- Published in:
- International Journal of Dermatology, 2014, v. 53, n. 3, p. 267, doi. 10.1111/ijd.12208
- By:
- Publication type:
- Article
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 4, p. e183, doi. 10.1016/j.clml.2024.11.014
- By:
- Publication type:
- Article
Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 116, doi. 10.1016/j.clml.2024.07.019
- By:
- Publication type:
- Article
MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S408, doi. 10.1016/S2152-2650(21)01919-4
- By:
- Publication type:
- Article
Poster: MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S246, doi. 10.1016/S2152-2650(21)01551-2
- By:
- Publication type:
- Article
Long-Term Follow-Up of Patients with Monoclonal Gammopathy of Undetermined Significance after Kidney Transplantation.
- Published in:
- American Journal of Nephrology, 2012, v. 35, n. 4, p. 365, doi. 10.1159/000337482
- By:
- Publication type:
- Article
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?
- Published in:
- Nutrition & Cancer, 2018, v. 70, n. 7, p. 1088, doi. 10.1080/01635581.2018.1502328
- By:
- Publication type:
- Article
S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Peripheral T-cell lymphoma involving the placenta.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Granulomatous angiitis of the spinal cord associated with Hodgkin's disease.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70006
- By:
- Publication type:
- Article
Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
- By:
- Publication type:
- Article
Treatment intensification might not improve survival in high‐grade B‐cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 776, doi. 10.1002/hon.3130
- By:
- Publication type:
- Article
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 39, doi. 10.1002/hon.3098
- By:
- Publication type:
- Article
Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 658, doi. 10.1002/hon.2919
- By:
- Publication type:
- Article
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemia.
- Published in:
- Leukemia & Lymphoma, 2023, v. 64, n. 8, p. 1490, doi. 10.1080/10428194.2023.2214026
- By:
- Publication type:
- Article
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 12, p. 2879, doi. 10.1080/10428194.2022.2102623
- By:
- Publication type:
- Article
Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 13, p. 3152, doi. 10.1080/10428194.2021.1941931
- By:
- Publication type:
- Article
Body mass index and survival of patients with lymphoma.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 11, p. 2671, doi. 10.1080/10428194.2021.1929956
- By:
- Publication type:
- Article
Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder.
- Published in:
- Clinical Infectious Diseases, 1995, v. 20, n. 5, p. 1346, doi. 10.1093/clinids/20.5.1346
- By:
- Publication type:
- Article
Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
- Published in:
- British Journal of Haematology, 1992, v. 80, n. 4, p. 466, doi. 10.1111/j.1365-2141.1992.tb04559.x
- By:
- Publication type:
- Article
Blood Transfusion and Risk of Non-Hodgkin's Lymphoma.
- Published in:
- American Journal of Epidemiology, 2009, v. 149, n. 12, p. 1113
- By:
- Publication type:
- Article
Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
- Published in:
- International Journal of Dermatology, 2002, v. 41, n. 6, p. 352, doi. 10.1111/j.1365-4632.2002.01501.x
- By:
- Publication type:
- Article
Long-Term Foliow-Up of a CHOP-Based Regimen with Maintenance Therapy and Central Nervous System Prophylaxis in Lymphoblastic Non-Hodgkin's Lymphoma.
- Published in:
- Leukemia & Lymphoma, 1994, v. 15, n. 3/4, p. 291, doi. 10.3109/10428199409049726
- By:
- Publication type:
- Article
Management of Stage IE Primary Gastric Lymphoma.
- Published in:
- Acta Haematologica, 1995, v. 94, n. 2, p. 59, doi. 10.1159/000203975
- By:
- Publication type:
- Article
Bone involvement on PET/CT predicts event‐free survival in follicular lymphoma Grade 3B.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 2, p. e41, doi. 10.1111/bjh.16974
- By:
- Publication type:
- Article
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 661, doi. 10.1111/bjh.16425
- By:
- Publication type:
- Article
Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. 820, doi. 10.1111/bjh.15997
- By:
- Publication type:
- Article
Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 524, doi. 10.1111/bjh.15720
- By:
- Publication type:
- Article
Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 149, doi. 10.1111/bjh.14922
- By:
- Publication type:
- Article
Human Pegivirus infection and lymphoma risk and prognosis: a North American study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 5, p. 644, doi. 10.1111/bjh.15416
- By:
- Publication type:
- Article
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near <italic>MYC</italic>/<italic>PVT1</italic> predicts patient outcome in two independent cohorts.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
- By:
- Publication type:
- Article
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 50, doi. 10.1111/bjh.14813
- By:
- Publication type:
- Article
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 3, p. 427, doi. 10.1111/bjh.14688
- By:
- Publication type:
- Article
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 867, doi. 10.1111/bjh.14007
- By:
- Publication type:
- Article
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 530, doi. 10.1111/bjh.13634
- By:
- Publication type:
- Article
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 56, doi. 10.1111/bjh.13389
- By:
- Publication type:
- Article
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 358, doi. 10.1111/bjh.12753
- By:
- Publication type:
- Article